EUVIMEDEUVIMED entdecken
Systematische Übersicht

Current evidence and clinical utility of phenobarbital for alcohol withdrawal syndrome

Yoshito Nishimura, Horyun Choi, Bridget Colgan, Harrison Kistler, Francisco Mercado

European Journal of Internal Medicine · 2023

DOI: 10.1016/j.ejim.2023.03.006 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift European Journal of Internal Medicine, 2023. Verfasst von Yoshito Nishimura und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, John A. Burns School of Medicine, University of Hawai'i, Honolulu, HI, 96813, United States of America. Electronic address: y…. Hauptthemen laut MEDLINE: Substance Withdrawal Syndrome, Alcoholism, Alcohol Withdrawal Delirium. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 50 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Phenobarbital (PB) has been acknowledged among clinicians as a potential alternative to benzodiazepines (BZD) to decrease the need for hospital length of stay and complications associated with alcohol withdrawal syndrome (AWS). However, the level of evidence, including appropriate dosing, is unclear. We aim to summarize the evidence regarding PB used in AWS and provide future agendas for research. METHODS: Following the PRISMA guidelines, we searched MEDLINE, EMBASE, ClinicalTrials.gov, and WHO ICTRP for all peer-reviewed articles and clinical trials using keywords including"alcohol withdrawal", "delirium tremens", "phenobarbital," and "barbiturate" from their inception to September 18, 2022. RESULTS: We included 20 articles, nine in the emergency department (ED) and 11 in the general floors or intensive care units (ICUs). Studies performed in the ED included two RCTs, although both suffered from a considerably small sample size. Six studies done in the general floors or ICUs compared PB and BZD monotherapy, while four compared the utility of adjunct PB in addition to BZD compared with BZD monotherapy and one was a database study without specific dosing information. Overall, there was considerable heterogeneity in PB dosing, measured outcomes, and AWS severity measurement scales. CONCLUSION: This systematic review summarizes the current evidence related to PB use in AWS. While considerable heterogeneity exists among studies available, PB as monotherapy without BZD may be a safe and effective alternative in AWS treatment. Future prospective studies or trials should focus on the standardization of PB dosing and outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Substance Withdrawal SyndromeAlcoholismAlcohol Withdrawal DeliriumHumansProspective StudiesRetrospective StudiesPhenobarbitalBenzodiazepines

Stichwörter der Autor:innen

Alcohol withdrawalDelirium tremensPhenobarbitalSystematic review

Substanzen

PhenobarbitalBenzodiazepines

Autor:innen und Institutionen

  • Department of Medicine, John A. Burns School of Medicine, University of Hawai'i, Honolulu, HI, 96813, United States of America. Electronic address: yoshiton@hawaii.edu.
  • Department of Medicine, John A. Burns School of Medicine, University of Hawai'i, Honolulu, HI, 96813, United States of America.
  • Department of Medicine, Tripler Army Medical Center, Honolulu, HI 96859, United States of America.
  • Department of Medicine, John A. Burns School of Medicine, University of Hawai'i, Honolulu, HI, 96813, United States of America; Department of Medicine, Tripler Army Medical Center, Honolulu, HI 96859, United States of A…

Zitieren

APA

Nishimura, Y., Choi, H., Colgan, B., Kistler, H., & Mercado, F. (2023). Current evidence and clinical utility of phenobarbital for alcohol withdrawal syndrome. European Journal of Internal Medicine. https://doi.org/10.1016/j.ejim.2023.03.006

Vancouver

Nishimura Y, Choi H, Colgan B, Kistler H, Mercado F. Current evidence and clinical utility of phenobarbital for alcohol withdrawal syndrome. European Journal of Internal Medicine. 2023. doi:10.1016/j.ejim.2023.03.006

BibTeX
@article{Nishimura2023,
  author = {Nishimura, Yoshito and Choi, Horyun and Colgan, Bridget and Kistler, Harrison and Mercado, Francisco},
  title = {Current evidence and clinical utility of phenobarbital for alcohol withdrawal syndrome},
  journal = {European Journal of Internal Medicine},
  year = {2023},
  doi = {10.1016/j.ejim.2023.03.006}
}
Kostenlos starten →